Medicare spending analysis for Pain Management providers
Pain Management accounts for $3.5B in Medicare payments across 22.6K providers.
The specialty's average markup of 5.1x is above the overall Medicare average of 3.77x.
AI-generated analysis based on Medicare payment data.
Providers in this specialty flagged by the ML v2 fraud detection model
| Year | Payments | Services | Providers | YoY Change |
|---|---|---|---|---|
| 2014 | $241.4M | 5.8M | 1.6K | — |
| 2015 | $305.1M | 7.1M | 1.9K | +26.4% |
| 2016 | $312.7M | 6.4M | 2.0K | +2.5% |
| 2017 | $338.3M | 6.8M | 2.1K | +8.2% |
| 2018 | $357.6M | 7.6M | 2.3K | +5.7% |
| 2019 | $393.1M | 8.5M | 2.4K | +9.9% |
| 2020 | $355.0M | 7.6M | 2.5K | -9.7% |
| 2021 | $417.4M | 8.5M | 2.6K | +17.6% |
| 2022 | $430.1M | 8.4M | 2.6K | +3.0% |
| 2023 | $387.8M | 8.5M | 2.7K | -9.8% |
| # | Provider | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| 1 | Hemal Mehta | TN | $4.5M | 5.4K | $841.55 |
| 2 | Ishmeet Singh | FL | $2.1M | 166.9K | $12.66 |
| 3 | Philip Sasso | PA | $1.4M | 27.6K | $51.08 |
| 4 | Blake Christensen | OK | $1.4M | 18.9K | $74.63 |
| 5 | David Lindenberg | CA | $1.3M | 18.8K | $71.72 |
| 6 | Thomas Coury | AZ | $1.3M | 21.5K | $58.60 |
| 7 | Salar Deldar | CA | $1.2M | 24.6K | $50.72 |
| 8 | George Soliman | FL | $1.2M | 48.0K | $25.54 |
| 9 | Kenneth Bradley | CA | $1.2M | 33.3K | $35.35 |
| 10 | Jason Fogg | KY | $1.2M | 301.0K | $3.84 |
| 11 | Nikesh Seth | AZ | $1.2M | 16.3K | $70.72 |
| 12 | John Paul Malayil | AZ | $1.1M | 32.7K | $35.00 |
| 13 | Stephen Markewich | AK | $1.1M | 12.5K | $86.98 |
| 14 | Naumit Bhandari | TX | $1.1M | 39.9K | $27.05 |
| 15 | Christopher Mocek | AR | $1.0M | 19.6K | $52.72 |
| 16 | John Ruxer | KY | $1.0M | 12.7K | $79.88 |
| 17 | Michael Baskin | FL | $944.0K | 18.4K | $51.43 |
| 18 | Lindsey Job | FL | $937.5K | 27.3K | $34.31 |
| 19 | Omolade Maurice-Diya | CA | $936.1K | 21.8K | $42.88 |
| 20 | Ashraf Hanna | FL | $935.0K | 49.3K | $18.96 |
| 21 | Shaun Gabriel | CO | $889.8K | 20.4K | $43.53 |
| 22 | Jason Rosenberg | SC | $880.7K | 65.1K | $13.53 |
| 23 | Javid Baksh | NC | $869.7K | 7.2K | $121.13 |
| 24 | Phung Pham | FL | $869.4K | 11.6K | $74.80 |
| 25 | Arif Hussain | IN | $865.4K | 12.3K | $70.60 |
| Code | Description | Payments | Services | Avg/Service |
|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | $88.1M | 962.4K | $91.56 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | $34.3M | 538.4K | $63.67 |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | $21.6M | 137.8K | $157.14 |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | $19.0M | 65.3K | $291.39 |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | $18.9M | 159.0K | $118.59 |
| 62323 | Injection of substance into lower spine canal using imaging guidance | $17.4M | 139.1K | $125.28 |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | $15.3M | 109.4K | $139.85 |
| 80307 | Testing for presence of drug, by chemistry analyzers | $9.5M | 158.7K | $60.04 |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | $8.9M | 66.7K | $133.73 |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | $8.7M | 77.1K | $113.06 |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | $7.8M | 101.8K | $76.35 |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $7.4M | 38.2K | $193.10 |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | $6.6M | 14.8K | $446.14 |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | $5.8M | 24.3K | $239.56 |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | $5.7M | 43.0K | $132.82 |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | $4.8M | 32.6K | $146.39 |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | $4.5M | 65.5K | $69.48 |
| Q4217 | Woundfix, biowound, woundfix plus, biowound plus, woundfix xplus or biowound xplus, per square centimeter | $4.5M | 5.3K | $852.35 |
| 77002 | Fluoroscopic guidance for needle placement | $4.4M | 61.1K | $72.55 |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | $4.4M | 33.8K | $130.39 |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.